The key role of rubella virus glycoproteins in the formation of immune response, and perspectives on their use in the development of new recombinant vaccines
- PMID: 26776468
- DOI: 10.1016/j.vaccine.2016.01.010
The key role of rubella virus glycoproteins in the formation of immune response, and perspectives on their use in the development of new recombinant vaccines
Abstract
Rubella is a highly contagious viral disease which is mostly threatens to women of reproductive age. Existent live attenuated vaccines are effective enough, but have some drawbacks and are unusable for a certain group of people, including pregnant women and people with AIDS and other immunodeficiency. Thereby the development of alternative non-replicating, recombinant vaccines undoubtedly is needed. This review discusses the protein E1 and E2 role in formation of immune response and perspectives in development of new generation recombinant vaccines using them.
Keywords: Development of recombinant vaccines; Epitopes; Glycoproteins E1 and E2; Rubella virus.
Copyright © 2016 Elsevier Ltd. All rights reserved.
Similar articles
-
A recombinant rubella virus E1 glycoprotein as a rubella vaccine candidate.Vaccine. 2004 Dec 9;23(4):480-8. doi: 10.1016/j.vaccine.2004.06.030. Vaccine. 2004. PMID: 15530696
-
The influence of N-linked glycosylation on the antigenicity and immunogenicity of rubella virus E1 glycoprotein.Virology. 1992 Oct;190(2):876-81. doi: 10.1016/0042-6822(92)90929-j. Virology. 1992. PMID: 1381541
-
Mapping T-cell epitopes of rubella virus structural proteins E1, E2, and C recognized by T-cell lines and clones derived from infected and immunized populations.J Med Virol. 1993 Jul;40(3):175-83. doi: 10.1002/jmv.1890400302. J Med Virol. 1993. PMID: 7689090
-
[Advances in molecular biology of rubella virus structural proteins].Zhonghua Nan Ke Xue. 2008 Jul;14(7):645-9. Zhonghua Nan Ke Xue. 2008. PMID: 18686389 Review. Chinese.
-
[Synthetic antigens in the diagnosis of viral diseases].Vopr Virusol. 1989 Mar-Apr;34(2):133-9. Vopr Virusol. 1989. PMID: 2474902 Review. Russian. No abstract available.
Cited by
-
Design of a chimaeric antigen and its use in the detection of IgG antibodies against rubella virus.Virol J. 2022 Feb 23;19(1):33. doi: 10.1186/s12985-022-01760-y. Virol J. 2022. PMID: 35197095 Free PMC article.
-
Performance of Zika Assays in the Context of Toxoplasma gondii, Parvovirus B19, Rubella Virus, and Cytomegalovirus (TORCH) Diagnostic Assays.Clin Microbiol Rev. 2019 Dec 11;33(1):e00130-18. doi: 10.1128/CMR.00130-18. Print 2019 Dec 18. Clin Microbiol Rev. 2019. PMID: 31826871 Free PMC article. Review.
-
Rubella virus seropositivity after infection or vaccination as a risk factor for multiple sclerosis.Eur J Neurol. 2024 Oct;31(10):e16387. doi: 10.1111/ene.16387. Epub 2024 Jul 18. Eur J Neurol. 2024. PMID: 39023088 Free PMC article.
-
Characterization of rubella-specific humoral immunity following two doses of MMR vaccine using proteome microarray technology.PLoS One. 2017 Nov 16;12(11):e0188149. doi: 10.1371/journal.pone.0188149. eCollection 2017. PLoS One. 2017. PMID: 29145521 Free PMC article.
-
Prevalence of human papillomavirus in Jeddah, Saudi Arabia.Ann Saudi Med. 2019 Nov-Dec;39(6):403-409. doi: 10.5144/0256-4947.2019.403. Epub 2019 Dec 5. Ann Saudi Med. 2019. PMID: 31804132 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
